IRCT20200630047962N1招募中未知
Evaluation of the effectiveness of progressive muscle relaxation technique on the level of covid-19 anxiety of pregnant women covered by the Ayat Comprehensive Health Services Center of Tehran University of Medical Sciences
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •Satisfaction to participate in research
- •Gestational age less than 32 weeks
- •Literacy for reading and writing
- •Access to a smartphone, computer or laptop on the web
- •Mild to moderate covid-19 anxiety levels
排除标准
- •History of a confirmed psychiatric illness
- •History of receiving any psychotherapy in the last 6 months
- •High risk pregnancy
- •Severe covid-19 anxiety level
- •Visual and auditory impairment
- •Immigration in the last 6 months
- •Hospitalized in the last 6 months
- •Loss of a family member in the last 6 months
- •Suicidal thoughts
- •History of poor pregnancy outcomes such as preterm labor, miscarriage, stillbirth and fetal malformations in the past year
研究者
相似试验
招募中
不适用
Evaluation of the effectiveness of progressive muscle relaxation on maternal and neonatal outcomes on primary parous women with preeclampsiaPreeclampsia.Eclampsia in pregnancy, unspecified trimesterO15.00IRCT20180110038302N6Alborz University of Medical Sciences88
已完成
2 期
Effect of progressive muscle relaxation technique on fatigue in patientsChronic renal failureHemodialysis.IRCT2016092514333N59Vice chancellor for research, Kermanshah University of Medical Sciences60
已完成
不适用
Strength Training in Gestational Diabetes Mellitus (GDM)Gestational DiabetesMetabolic and Endocrine - DiabetesACTRN12605000378628International Diabetes Institute70
尚未招募
Unknown
Evaluation of the effectiveness of a continuous multidisciplinary follow-up model for functional recovery of post-intensive care patients.Post Intensive Care Syndromepostintensive care syndrome PICS Follow upMeSH Unique ID: C000657744JPRN-jRCT1032230546Takiguchi Chie800
进行中（未招募）
1 期
To evaluate the efficacy beyond progression of vemurafenib combined with cobimetinib associated with local treatment compared to second-line treatment in patients with BRAFV600 mutation-positive metastatic melanoma in focal progression with first-line combined vemurafenib and cobimetinib.BRAFV600 mutation-positive metastatic melanoma in focal progressionMedDRA version: 21.1Level: LLTClassification code 10053571Term: MelanomaSystem Organ Class: 100000004864EUCTR2017-003038-98-ITINTERGRUPPO MELANOMA ITALIANO120